Efficient transduction of primary hematopoietic cell types by oncoretroviral vectors and lentiviral vectors with a variety of different envelope pseudotypes has proven to be difficult. We recently developed a lentiviral vector based upon a modified Sindbis virus envelope that allows targeted transduction via antibody recognition to specific cells in unfractionated cell populations. However, similar to other envelope pseudotypes, the utility of this vector for some primary hematopoietic cells was limited by low transduction efficiencies. Here, we report that transient treatment of cells with low pH culture medium immediately following infection results in marked enhancements in transduction efficiency for primary hematopoietic cells. In combination with antibody directed targeting, this simple technique expands the utility of targeting transduction to specific cells in mixed populations of primary cells.
Introduction
Pseudotyping of retrovirus vectors by substitution of the native envelope protein with one that uses different cell surface receptors is commonly used as a means to alter gene transduction efficiency and host cell tropism (Lewis et al., 2001; Kobinger et al., 2001; Beyer et al., 2002; Liu et al., 2004; Kahl et al., 2004; Watson et al., 2002) . Envelope proteins of vesicular stomatitis virus (VSV-G) and retroviruses, such as amphotrophic MLV, RD114 and GALV, have been used for pseudotyping retrovirus vectors (Mochizuki et al., 1998; Naldini et al., 1996; Burns et al., 1993; Sandrin et al., 2002; Lusso et al., 1990) . Although the receptors for these envelope proteins are expressed ubiquitously allowing infection of multiple cell types, certain types of cells express these receptors poorly resulting in inefficient gene transduction (Unutmaz et al., 1999; Serafini et al., 2004; Orlic et al., 1996; Relander et al., 2002; von Laer et al., 1998; Kurre et al., 2001; Janssens et al., 2003) . The ability to redirect the binding of viral vectors to any desired cell surface molecule, provided it is abundantly expressed on the entire target cell population, would in theory permit efficient transduction to be achieved for any type of target cell (Sandrin et al., 2003) . This approach would also allow targeting of specific cell types in mixed populations (Sandrin et al., 2003) . The ability to target and efficiently transduce specific subpopulations of cells within unfractionated primary cell populations would be of importance for laboratory experiments as well as for several types of gene therapy applications. Direct infection of cell subpopulations would be less labor-intensive and more cost-effective. In addition, it is well recognized that manipulations involving purified cell subpopulations often alter the functional properties of the cells. Experiments and clinical protocols whereby specific subsets of hematopoietic cells are purified prior to infusion would be Virology 355 (2006) 71 -81 www.elsevier.com/locate/yviro greatly simplified if specific cell types could be targeted directly in non-fractionated populations. Many attempts have been made to develop efficient and generally useful targeting vectors. Most strategies are based upon alteration of the retroviral envelope protein to modify its binding specificity. Inserting peptides, ligands or single-chain antibodies into the receptor-binding region of the envelope protein is a common strategy (Martin et al., 2002; Jiang and Dornburg, 1999; Han et al., 1995; Marin et al., 1996; Nilson et al., 1996; Somia et al., 1995; Valsesia-Wittmann et al., 1994) . Bridging virus and cells with anchoring proteins is another way to redirect the binding specificity of the virus (Boerger et al., 1999; Roux et al., 1989) . However, these approaches are not generally applicable, due to low titers and/or poor specificity (Kasahara et al., 1994; Zhao et al., 1999) .
We developed a targeted oncoretroviral/lentiviral gene transduction strategy by pseudotyping retroviral vectors with a chimeric Sindbis virus envelope protein (Morizono et al., 2001) . Sindbis virus has two integral envelope proteins, E1 and E2, and they form a trimer of the heterodimer. E2 mediates binding to target cells, and E1 mediates fusion between the viral envelope and the target cell membrane. A low pH environment in the endosome elicits fusion activity of the E1 protein, which then mediates fusion of the envelope to the endosome membrane and penetration of virions into the cytoplasm (Glomb-Reinmund and Kielian, 1998) . We modified the native Sindbis virus envelope protein by insertion of the Fc binding region of protein A (ZZ domain) in the receptor-binding region. The ZZ domain can bind the Fc region of monoclonal antibodies; therefore, virus can be conjugated with specific antibodies recognizing any desired cell surface molecule. We demonstrated successful antibody-mediated targeting in vitro within populations consisting of mixtures of cells bearing or not bearing the target receptor. We further modified the ZZ SINDBIS envelope protein to optimize targeting specificity for in vitro and in vivo applications (Morizono et al., 2005) .
Some types of hematopoietic cells are relatively resistant to gene transduction by pseudotyped retroviral vectors, including our targeting vectors. In some cases, cells are refractory to transduction because of low expression levels of the receptor for envelope proteins. For example, human hematopoietic stem cells do not express high levels of Pit-1 and Pit-2, which are receptors for GALV and amphotropic MLV envelope, respectively, resulting in poor transduction efficiencies by vectors pseudotyped with the GALV and the amphotropic MVL envelopes (Orlic et al., 1996; Relander et al., 2002; von Laer et al., 1998; Kurre et al., 2001) . Human and murine primary B lymphocytes are also relatively resistant to VSV-G-pseudotyped vectors, due to low levels of expression of the VSV-G receptor (Serafini et al., 2004; Unutmaz et al., 1999; Janssens et al., 2003) . In the case of our targeting vectors, the targeted cell surface molecules, such as HLA, are abundantly expressed on the cells, so blockage of gene transduction appears to occur after binding, most likely at the fusion step.
The fusion activity of certain alphavirus envelope proteins was previously shown to be activated by artificial acidification of the virus. In one study, Semliki Forest Virus on target cells was exposed to low-pH culture medium, resulting in artificial fusion occurring at the surface of the infected cells (White et al., 1980) . In another study, Sindbis virus was incubated with liposome, then exposed to acidic buffer, resulting in fusion between the virus and the liposomes (Smit et al., 1999) .
Therefore, we established conditions to enhance the efficiency of transduction to primary cells in non-fractionated populations. We combined our current targeting strategy with artificial activation of fusion by transient low-pH treatment. This new transduction method was examined for targeted gene transduction of specific cell types, and we demonstrate efficient transduction to cells currently refractory to oncoretoroviral/ lentiviral gene transduction, including primary hematopoietic cells in non-purified bulk populations.
Results
Certain hematopoietic cell types are refractory to lentiviral gene transduction Infectivity of pseudotyped lentiviral vectors is restricted in some hematopoietic cells. We constructed variants of the previously described targeting envelope derived from the Sindbis virus in order to enhance infectivity. Transduction efficiency was tested using virus conjugated to anti-Human leukocyte antigen (HLA) Class I antibodies. A mutation in the E1 region was reported to mediate fusion in the absence of the lipid cholesterol (Lu et al., 1999) . Insertion of the mutation into our targeting vector broadened the host range of the vector to some hematopoietic cell types (data not shown). Another mutation in the E2 region (m6) was found to increase the infectivity of the targeting vector by an unknown mechanism (Morizono et al., 2005) . The envelope protein bearing these two mutations, termed M6SGNUTR, enhanced infectivity 5-to 10-fold for some hematopoietic cells over the parental targeting envelope (ZZ SINDBIS (Morizono et al., 2001 (Morizono et al., , 2005 ) (Fig. 1a) (data not shown). Although the vector transduced various types of cells with higher efficiency, certain cell types remained relatively refractory to transduction (Table 1) . For example, Jurkat and Raji cells were efficiently transduced using anti-HLA antibody, whereas KG1a and MLCD34 cells were not (Table 1 , Fig. 1b ).
Low pH treatment enhances infectivity of M6SGNUTR pseudotypes
The target receptor HLA class I is abundantly expressed on those refractory cell types (Fig. 1c) . We also found that M6SGNUTR pseudotypes efficiently bound to those cells when they are conjugated with anti-HLA class I antibody (data not shown). Therefore, we hypothesized that the block for transduction was at a step in viral entry subsequent to binding of virus to the target receptor. An earlier report for Semliki Forest Virus and Sindbis virus demonstrated that reduction of the pH in the culture medium following incubation of virus with liposome or cells at 4°C triggered fusion (White et al., 1980; Smit et al., 1999) . We tested whether treatment of the virus after binding to the cell with low pH medium might enhance infectivity of the M6SGNUTR lentiviral vector. The two resistant cell lines showed a 20-to 25-fold enhancement of infection when treated immediately following exposure to virus with pH 5.0 buffer for 1 min (Table 1 , Fig. 2a ). EGFP expression with low pH treatment was blocked by reverse transcriptase inhibitor, excluding the possibility of pseudotransduction by virion-associated EGFP protein (data not shown). Additionally, EGFP expression was very low immediately after transduction, reaching a maximal level at 3 days post-infection, and was maintained for at least 7 days postinfection (data not shown). Interestingly, pseudotypes with a The same number of each type of cells (5 × 10 4 ) was infected with the same amount of each virus (20 ng of HIV p24 in 200 μl of medium). Some of the infected cells were then received low pH treatment (pH 5, 1 min, 20°C). Three days post-infection, EGFP expression was analyzed by flow cytometry. commonly used envelope from another virus (VSV-G) dependent on low pH in the endosomes were not affected by low pH treatment (Fig. 2a) .
We chose two particularly refractory cell lines, KGIA and MLCD34, for further investigation of enhanced transduction of low pH (Fig. 2a) . Incubation of the MLCD34 cells with the M6SGNUTR vector sometimes caused aggregation of the cells likely due to virus bridging of cells bearing the target receptor. After the low pH treatment, the cells formed syncytia resulting from fusion of aggregated cells (Fig. 2b) . This observation is consistent with activation of fusion between virus and cell by the low pH treatment. Since "fusion from without" decreases the viability of target cells, we seeded target cells on retronectincoated plates to prevent aggregation of cells. Target cells seeded on retronectin-coated plates did not fuse after low pH treatment, therefore, the cell viability was maintained.
Optimization of low-pH-mediated enhancement of transduction
We investigated the optimal conditions for the low pH enhancement of infectivity. The maximal enhancement for transduction of MLCD34 cells was observed between pH 4.5 4 cells each) were incubated with the same amount (200 ng HIV p24) of cppt2e (VSV-G) or cppt2e (M6SGNUTR) with or without anti-HLA for 2 h. After infection, virus was removed, then the cells were resuspended in citric acid buffer (pH 5) for 1 min at room temperature. The cells were washed after low pH treatment and cultured in normal culture medium for 3 days. EGFP expression was analyzed by flow cytometry. (b) "Fusion from without" was observed on MLCD34 cells, which were infected with cppt2e (M6SGNUTR) with anti-CD45 then exposed to citric acid buffer (pH 5). The photomicrograph was taken 10 min after removal of citric acid buffer and resuspension of the cells in normal culture medium. and pH 5.5 (Fig. 3a) . Enhanced transduction did not occur when using pseudotypes with envelopes derived from pH-dependent VSV-G-or pH-independent RD114/TR in the range of pH investigated (pH 4 to pH 6). Similar results were observed for another transduction refractory cell line KGIA (Fig. 3b) . Since no adverse effects on cells were observed at pH 5.5, this pH was used for all the following experiments. Optimal time periods for low pH treatment to obtain maximal transduction efficiencies were investigated (Fig. 3c) . Maximal enhancement was observed with a duration as short as 5 s. Shorter durations were not feasible, given the technical manipulations involved. These conditions of low pH treatment were consistent with those for artificial fusion of alphaviruses with cells, which occurred within a few seconds (White et al., 1980) . Of note, low pH treatment of the targeting virus before infection eliminated infectivity (< 0.2%) of the virus, indicating that the pH-induced enhancement must occur after virus binding. Based upon these results, cells were treated at pH 5.5 for 10 s for all subsequent experiments. The same levels of transduction were observed at temperatures of infection at 4°C, 20°C and 37°C (Fig. 3d) . Therefore, low pH treatment was performed at pH 5.5 for 10 s at room temperature. We also investigated whether the MOI of the virus affected the transduction efficiency with low pH treatment (Fig. 3e) . Regardless of MOI, enhancement of gene transduction with low pH treatment occurred efficiently, demonstrating that this method is applicable for infecting any number of cells and with any amount of virus.
Enhanced transduction to specific cells in unfractionated primary cell populations
The primary advantage of the targeting vector is the ability to infect specific cells within a population without the need for physical purification of cell subpopulations. We next tested targeted transduction of CD4+ T-cells in an unfractionated population (Fig. 4a) . Similar to the previously described results with some cell lines, transduction of primary CD4+ T cells was inefficient, even with antibody directed to the highly abundant HLA class I molecule. Low pH treatment enhanced transduction efficiencies significantly (Fig. 4a) . As expected, infection targeted to HLA class I resulted in infection of both CD4+ and CD4− populations. In contrast, infection with an anti-CD4 antibody followed by low pH treatment resulted in specific and more efficient infection for the CD4+ population of the cells. Thus, the use of specific targeting antibodies combined with low pH treatment allows more effective targeted transduction of specific primary lymphocyte populations in a non-fractionated PBMC population.
Primary B cells are notoriously difficult to transduce by VSV-G-pseudotyped lentiviral vectors (Serafini et al., 2004; Unutmaz et al., 1999; Janssens et al., 2003) . CD19+CD20+ B cells comprise approximately 7% of total white blood cells (Fig. 4b) . VSV-G pseudotypes transduce only up to 6.6% of B cells (CD19+ population) in a non-targeted fashion at the same MOI used to transduce more than 50% of CD4+ cells (Fig.  4c) . Without low pH treatment, transduction of bulk PBMC populations with vector conjugated to either the anti-CD19 or the CD20 antibody results in 4% and 15% targeted transduction of the CD19+ population, respectively. The CD20 targeting vector transduced B cells more efficiently than VSV-G pseudotypes even without low pH treatment. Low pH treatment further enhances transduction efficiency approximately 4-fold with anti-CD19 antibody and 1.3-fold with anti-CD20. Thus, efficient and targeted transduction of primary Bcell populations in non-fractionated peripheral blood cells can be achieved by the targeting vector in combination with low pH treatment.
Discussion
Our results demonstrate that transient treatment with low pH culture medium immediately following infection by a lentiviral targeting vector pseudotyped with a modified Sindbis virus envelope can enhance infectivity 1.3-to greater than 40-fold depending on the cell type. The treatment of cells with lowered pH is a rapid and simple technique that is suitable for enhancing transduction of multiple cell types. Most importantly, low pH treatment can significantly enhance transduction efficiency to primary cells and thereby enhances the utility of our strategy to target specific cell types within non-fractionated hematopoietic cell populations such as hematopoietic stem cells, T cells and B cells.
The mechanism of action for the pH-induced enhancement of transduction is likely related to the natural process of Sindbis virus infection whereby endocytosis of the virus into low pH endosomes results in fusion of the virus to the endosomal membrane and entry of the viral capsid into the cytoplasm. The extracellular change to low pH may mimic in part the endosomal low pH eliciting conformational changes that induce fusion with the endosome membranes (Edwards et al., 1983; Paredes et al., 2004) . Consistent with this interpretation, treatment of free virions with low pH abolished infectivity, indicating that pH-induced changes leading to entry occur after virus binding to the target receptor (Edwards et al., 1983) . However, our studies also show that the pH-induced changes are independent of the native Sindbis virus receptor and can occur with multiple target receptors recognized by specific antibodies. For wild type Sindbis virus, other investigators reported that the exposure to low pH was required to establish conditions for membrane fusion but that fusion to the cell membrane did not occur until return to neutral pH (Paredes et al., 2004) . It is also interesting to note that this low pH-induced enhancement of infectivity is not true for all viruses (such as VSV-G) that are pH-dependent for infection. One model for the pH-induced enhancement is that the Sindbis envelope undergoes a conformational change under low pH conditions, allowing formation of contacts with as yet unidentified cell surface molecules and that these interactions subsequently lead to virus-cell fusion.
The ability to efficiently transduce and target specific cells in unfractionated populations of primary cells could have several applications in the laboratory or in clinical settings. Fractionation protocols can often be labor-intensive and expensive. In addition, manipulations involved in purifying subpopulations of cells may alter functional properties present in more natural non-fractionated populations (Kay et al., 1983; Wang et al., 2004; Koh et al., 2005; Simonelli et al., 1992) . Multiple experimental and clinical protocols exist whereby specific subsets of CD34+ cells, T cells, B cells and/or dendritic cells are purified prior to reinfusion (Zambidis et al., 1997; Severino et al., 2003; Wendtner et al., 2004; Monahan and Salgaller, 1999; Willemsen et al., 2003; Schmidt et al., 2003; Hacein-Bey-Abina et al., 2002) for expression of therapeutic transgenes, immunoregulatory genes, cytokines and antigens. For example, chimeric T-cell receptors recognizing tumor-associated antigens or viral antigens have been introduced into purified CD8+ T cells to elicit a cytotoxic immune response to cancer cells or virusinfected cells (Hacein-Bey-Abina et al., 2002; Severino et al., 2003) . Purification of B cells and transduction ex vivo with specific antigens has been utilized to induce tolerance to the antigens (Zambidis et al., 1997) . In each of these situations, efficient targeted transduction in a bulk hematopoietic cell population could facilitate the protocols and minimize the ex vivo manipulations of cells that may potentially induce loss of function and viability.
Insertional mutagenesis leading to the development of malignant clones of transduced cells was observed as a serious adverse effect in clinical trials involving the therapeutic transduction of the common-γ chain transgene into X-linked SCID patients (Hacein-Bey-Abina et al., 2003) . In these studies, the requirement for high multiplicities of infection (MOI) required to achieve effective transduction could increase retroviral integration events in cells expressing high levels of viral receptor and thereby increase the probability of insertional mutagenesis in those cells. The use of low pH treatment and targeting receptors such as HLA that are uniformly expressed at high levels in the population should maximize the transgene expression while minimizing the risk of insertional mutagenesis.
The relatively simple strategy of transient low pH treatment of modified Sindbis targeting vectors brings us closer to the goal of achieving high efficiency transduction of any desired cell type, particularly within non-fractionated populations of primary cells. Greater understanding of the entry properties of the antibody-conjugated envelopes should further enhance their utility.
Materials and methods

Cells
MLCD34 cells were obtained from Dr. Robert Donahue (NHLBI, MA) and cultured in RPMI (Invitrogen, Carlsbad, CA) with 20% fetal calf serum (FCS) and antibiotics (100U of penicillin/ml and 100 μg of streptomycin/ml). Jurkat cells, KG1a cells and Raji cells were cultured in RPMI with 10% FCS and the antibiotics. MLCD34 is a line of immortalized CD34-positive cells derived from cadaveric bone marrow (Lawman et al., 1992) . Peripheral blood mononuclear cells (PBMC) were obtained, as previously described (Morizono, Bristol, Xie, Kung, and Chen) .
Plasmid RD114/TR was provided by Dr. FranÇois-LoÏc Cosset (Ecole Normale Superieure de Lyon, France) (Sandrin et al., 2002) . M6SGNUTR was constructed from the m6 mutant of pIntron ZZ and the SGN mutant of TOTO1101 (provided by Dr. Margaret Kielian, Albert Einstein College of Medicine) (Morizono et al., 2001; Lu et al., 1999) . Briefly, BsiW1-Xho1 fragment of the TOTO1101 (E1 region containing SGN mutation) was substituted with the identical region of the m6 mutant of pIntron ZZ SINDBIS.
Virus production
All lentivirus vectors were produced by calcium-phosphate-mediated transient transfection of 293T cells, as previously described (Morizono et al., 2001 (Morizono et al., , 2005 . Briefly, 293T cells (1.8 × 10 7 cells) were transfected with 12.5 μg of pCMVR8.2DVPR, 12.5 μg of SIN18-RhMLV-E with central polypurine tract (termed cppt2e) (Kung et al., 2005) and optimized amounts (5 to 10 μg) of envelope-expressing plasmids. The viral vectors were harvested in OptiMEM (Invitrogen) with 2% FCS and antibiotics. To concentrate the viral vector, the viruses were loaded onto Hanks balanced salt solution (HBSS) with 10% (Wt/Wt) sucrose, 0.3% BSA and 1 mM EDTA. The virus was then ultracentrifuged at 20,000 RPI for 90 min at 4°C by SW32 rotor (Beckman, Palo Alto, CA). The pellets were resuspended in a 100-fold lower volume of HBSS.
Virus infection of cell lines
Jurkat (5 × 10 4 cells) and CD34ML cells (5 × 10 4 cells) were infected with the same amount (200 ng of HIV p24) of cppt2e (VSV-G), cppt2e (RD114/TR), cppt2e (M6SGNUTR), cppt2e (M6SGNUTR) conjugated with anti-HLA class I (5 μg/ml) (Sigma, St. Louis, MO) or cppt2e (M6SGNUTR) conjugated with anti-CD45 (5 μg/ml) (ATCC). Cells were incubated in 1.5-ml tubes at 37°C for 2 h. After the viruses were rinsed, some of the infected cells were treated with citric acid buffer (0.131 M citric acid, 0.066 M Na 2 HPO 4 , pH 5) for 1 min at room temperature. The buffer was then changed to culture medium. Three days post-infection, EGFP expression was analyzed by flow cytometry. To test patterns of infectivity of each of the pseudotypes, various cells types (Raji, Jurkat, KG1a and MLCD34) were infected with different pseudotypes with or without low pH treatment. The same number of cells (5 × 10 4 ) were infected with the same amount of each virus (20 ng of HIV p24 in 200 μl of medium). Some of the infected cells then received low pH treatment (pH 5, 1 min, 20°C). Three days post-infection, EGFP expression was analyzed by flow cytometry. After the first finding of low-pH-mediated enhancement of transduction, infections were performed using retronectin-coated 24-well plates (Takara Bio Inc, Japan). To determine the optimal range of pH for transduction, cells (5 × 10 4 ) infected with viruses (200 ng of HIV p24) were treated with citric acid buffer of various pH levels for 1 min at room temperature; to determine the optimal duration of low pH treatment, cells (5 × 10 4 ) infected with viruses (200 ng of HIV p24) were treated with citric acid buffer (pH 5.5) for various durations at room temperature; to determine the optimal temperature for low pH treatment, cells (5 × 10 4 ) infected with viruses (200 ng of HIV p24) were treated with citric acid buffer (pH 5.5) for 10 s at various temperatures; to determine the effect of MOI on transduction, cells (5 × 10 4 ) were infected with various amounts of virus (6, 20, 60 or 200 ng of HIV p24) then treated with citric acid buffer pH 5.5 levels for 10 s at room temperature.
Flow cytometry for HLA class I
The same number of cells (5 × 10 5 ) were incubated with anti-HLA class I (Sigma) or isotype (mouse IgG2a) control antibody (eBioscience, San Diego, CA) (5 μg/ml) for 30 min at 4°C followed by incubation with FITC-conjugated goat anti-mouse IgG (1:200) (Cappel, Durham, NC) for 30 min at 4°C and analyzed by flow cytometry.
Virus infection of primary cells
For T-cell targeting, PBMC were cultured in T-cell growth medium [RPMI with 10% FCS, IL-2 (10 U/ml) and antibiotics] with phytohemaglutinin (25 μg/m) for 2 days. The cells were seeded in 24-well retronectin-coated plates (1 × 10 6 cells/ml) 1 day prior to infection. Cells were infected with the same amount (200 ng of HIV p24 in 200 μl of OptiMEM) of cppt2e (VSV-G), cppt2e (M6SGNUTR), cppt2e (M6SGNUTR) conjugated with anti-HLA class I (5 μg/ml) or cppt2e (M6SGNUTR) conjugated with anti-CD4 antibody (OKT4) (5 μg/ml) (ATCC) for 2 h at 37°C. After infection, 200 μl of citric acid buffer (pH 5) was added to some of the infected wells for 10 s. Viruses were then removed from wells, and cells were cultured in T-cell growth medium for 3 days. The PBMC were stained with 100 μl of anti-CD4-PE (5 μg/ml) (BD Bioscience, San Diego, CA) for 30 min on ice. The cells were then washed with FACS buffer and analyzed by flow cytomery. For B-cell targeting, PBMC were cultured in B-cell growth medium [RPMI with 10% FCS, IL-2 (10 U/ml), 2-mercaptoethanol (50 μM), IL-4 (10 ng/ml), soluble CD40 ligand (250 μg/ml) and antibiotics] for 1 day. The cells are seeded in 24-well retronectin-coated plates (1 × 10 6 cells/ml) 1 day prior to infection. Cells were infected with the same amount (200 ng of HIV p24 in 200 μl of OptiMEM) of cppt2e (VSV-G), cppt2e (M6SGNUTR), cppt2e (M6SGNUTR) conjugated with anti-CD19 (5 μg/ml) (eBioscience) or cppt2e (M6SGNUTR) conjugated with anti-CD20 antibody (5 μg/ml) (ATCC) for 2 h at 37°C. After the infection, 200 μl of citric acid buffer (pH 5) was added to some of the infected wells for 10 s. Viruses were then removed from wells, and cells were cultured in B-cell growth medium for 3 days. The PBMC were washed once with citric acid buffer (pH 3.3) then stained with 100 μl of anti-CD19-APC (5 μg/ml) (eBioscience) for 30 min on ice. The cells were analyzed by flow cytometry.
